Bank Julius Baer & Co’s Regenxbio RGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-8,503
| Closed | -$170K | – | 566 |
|
|
2023
Q2 | $170K | Sell |
8,503
-543
| -6% | -$10.9K | ﹤0.01% | 422 |
|
|
2023
Q1 | $171K | Sell |
9,046
-1,478
| -14% | -$27.9K | ﹤0.01% | 447 |
|
|
2022
Q4 | $239K | Sell |
10,524
-2,633
| -20% | -$59.8K | ﹤0.01% | 405 |
|
|
2022
Q3 | $348K | Buy |
13,157
+1,789
| +16% | +$47.3K | ﹤0.01% | 360 |
|
|
2022
Q2 | $281K | Sell |
11,368
-4,418
| -28% | -$109K | ﹤0.01% | 386 |
|
|
2022
Q1 | $524K | Sell |
15,786
-602
| -4% | -$20K | ﹤0.01% | 344 |
|
|
2021
Q4 | $536K | Buy |
16,388
+9,766
| +147% | +$319K | ﹤0.01% | 418 |
|
|
2021
Q3 | $278K | Sell |
6,622
-765
| -10% | -$32.1K | ﹤0.01% | 512 |
|
|
2021
Q2 | $287K | Sell |
7,387
-1,879
| -20% | -$73K | ﹤0.01% | 525 |
|
|
2021
Q1 | $316K | Sell |
9,266
-9,914
| -52% | -$338K | ﹤0.01% | 507 |
|
|
2020
Q4 | $870K | Buy |
19,180
+7,370
| +62% | +$334K | 0.01% | 375 |
|
|
2020
Q3 | $278K | Buy |
11,810
+10,474
| +784% | +$247K | ﹤0.01% | 462 |
|
|
2020
Q2 | $287K | Sell |
1,336
-8,446
| -86% | -$1.81M | ﹤0.01% | 421 |
|
|
2020
Q1 | $316K | Buy |
+9,782
| New | +$316K | 0.01% | 363 |
|